Position in NVS
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$384,276
+$9,733 QoQ
Shares Held
2,452
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#1,005
of 1,603 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Busey Bank holds $188,654,807 across 11 Drug Manufacturers - General names. NVS ranks #8 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
277,214 | $70,404,039 | |
| 2 | LLY |
ELI LILLY & Co
|
33,809 | $40,551,532 | |
| 3 | AMGN |
Amgen Inc
|
82,379 | $29,831,083 | |
| 4 | ABBV |
AbbVie Inc.
|
74,669 | $18,789,706 | |
| 5 | PFE |
Pfizer Inc
|
658,872 | $15,865,637 | |
| 6 | MRK |
Merck & Co., Inc.
|
76,140 | $9,783,989 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
37,053 | $2,134,993 | |
| 8 | NVS |
Novartis AG
This page
|
2,452 | $384,276 |
All Filings in NVS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $384,276 | 2,452 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $374,543 | 2,452 | Shares | Sole | 2026-04-28 | |
| 2025-12-31 | $345,915 | 2,509 | Shares | Sole | 2026-01-27 | |
| 2025-09-30 | $356,506 | 2,780 | Shares | Sole | 2025-10-15 | |
| 2025-06-30 | $349,597 | 2,889 | Shares | Sole | 2025-07-11 | |
| 2025-03-31 | $343,692 | 3,083 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $277,333 | 2,850 | Shares | Sole | 2025-01-23 | |
| 2024-09-30 | $328,497 | 2,856 | Shares | Sole | 2024-10-23 | |
| 2024-06-30 | $395,711 | 3,717 | Shares | Sole | 2024-07-23 | |
| 2024-03-31 | $400,365 | 4,139 | Shares | Sole | 2024-04-23 | |
| 2023-12-31 | $396,408 | 3,926 | Shares | Sole | 2024-01-25 | |
| 2023-09-30 | $367,307 | 3,606 | Shares | Sole | 2023-10-23 | |
| 2023-06-30 | $435,224 | 4,313 | Shares | Sole | 2023-07-21 | |
| 2023-03-31 | $424,396 | 4,613 | Shares | Sole | 2023-04-25 | |
| 2022-12-31 | $420,124 | 4,631 | Shares | Sole | 2023-01-23 | |
| 2022-09-30 | $354,662 | 4,666 | Shares | Sole | 2022-10-24 | |
| 2022-06-30 | $405,236 | 4,794 | Shares | Sole | 2022-08-03 | |
| 2022-03-31 | $419,094 | 4,776 | Shares | Sole | 2022-04-21 | |
| 2021-12-31 | $469,626 | 5,369 | Shares | Sole | 2022-01-25 | |
| 2021-09-30 | $459,848 | 5,623 | Shares | Sole | 2021-10-29 | |
| 2021-06-30 | $433,937 | 4,756 | Shares | Sole | 2021-07-22 | |
| 2021-03-31 | $410,560 | 4,803 | Shares | Sole | 2021-04-20 | |
| 2020-12-31 | $489,430 | 5,183 | Shares | Sole | 2021-01-20 | |
| 2020-09-30 | $652,460 | 7,503 | Shares | Sole | 2020-10-16 | |
| 2020-06-30 | $661,513 | 7,574 | Shares | Sole | 2020-07-21 | |
| 2020-03-31 | $693,569 | 8,412 | Shares | Sole | 2020-04-17 | |
| No filing history on record for this holder in this stock. | ||||||